Seaport Therapeutics, Inc. (SPTX)
19.98
-0.15
(-0.75%)
USD |
NASDAQ |
Nov 13, 16:00
19.93
-0.05
(-0.25%)
After-Hours: 19:59
Seaport Therapeutics Net Income (Quarterly) : -26.39M for Sept. 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -26.39M |
| June 30, 2026 | -62.60M |
| March 31, 2026 | -25.41M |
| December 31, 2025 | -24.14M |
| Date | Value |
|---|---|
| September 30, 2025 | -22.54M |
| June 30, 2025 | -15.08M |
| March 31, 2025 | -13.12M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Johnson & Johnson | 210.00M |
| Bristol Myers Squibb Co. | 2.162B |
| Harmony Biosciences Holdings, Inc. | 48.20M |
| ANI Pharmaceuticals, Inc. | 32.72M |
| Corcept Therapeutics, Inc. | 124.49M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 26.39M |
| EPS Diluted (Quarterly) | -0.4931 |
| Enterprise Value | 783.79M |
| Earnings Yield | -12.95% |
| Normalized Earnings Yield | -12.95 |